BioCentury
ARTICLE | Company News

Pharmacopeia up on GlaxoSmithKline deal

March 31, 2006 2:25 AM UTC

PCOP gained $0.91 (19%) to $5.73 on Thursday after announcing a drug discovery and development deal with GlaxoSmithKline (LSE:GSK; GSK) for undisclosed indications. The companies will jointly select t...